Showing 4541-4550 of 20465 results for "".
- Lonvoguran Ziclumeran Lowers Hereditary Angioedema Attackshttps://reachmd.com/news/lonvoguran-ziclumeran-lowers-hereditary-angioedema-attacks/2487603/Key Takeaways A single infusion of lonvoguran ziclumeran was associated with a substantially lower monthly hereditary angioedema attack rate than placebo. The phase 3, double-blind trial randomized 80 patients in a 2:1 ratio to one 50-mg intravenous do
- MAF-5 Score and Liver-Related Event Risk in a Screening Cohorthttps://reachmd.com/news/maf-5-score-and-liver-related-event-risk-in-a-screening-cohort/2487605/Key Takeaways Liver-related event risk rose across low-, intermediate-, and high-risk MAF-5 categories. Adding age improved discrimination and further separated risk within the same MAF-5 strata. Comparisons with FIB-4, APRI, and NFS plus comb
- Vasopressors or Fluids in Early Septic Shockhttps://reachmd.com/news/vasopressors-or-fluids-in-early-septic-shock/2487606/The optimal approach to early resuscitation in septic shock remains uncertain, with ongoing equipoise between the use of larger volumes of intravenous fluids to restore perfusion and the use of early vasopressor therapy with smaller fluid volumes to minimize potential harm from excess fluid
- Study: Off-Label Dosing Shows Limited Benefit for Brodalumab, Bimekizumab in Psoriasishttps://reachmd.com/news/study-off-label-dosing-shows-limited-benefit-for-brodalumab-bimekizumab-in-psoriasis/2487623/A systematic review published in Archives of Dermatological Research suggested deviations from approved dosing schedules offered limited clinical advantage in patients with plaque psoriasis, while maintaining similar safety. Investigators reviewed randomized controlled trials and
- Letter Questions Strength of Evidence Linking Hair Relaxers to Uterine Cancerhttps://reachmd.com/news/letter-questions-strength-of-evidence-linking-hair-relaxers-to-uterine-cancer/2487618/A recently published Letter to the Editor in the Journal of Drugs in Dermatology urged clinicians to interpret the growing body of research examining chemical hair relaxers and uterine cancer with caution, arguing that important methodological limitations prevent current evidence from es
- Nonsurgical vs Surgical ACL Care: Knee Function and Return to Sporthttps://reachmd.com/news/nonsurgical-vs-surgical-acl-care-knee-function-and-return-to-sport/2487599/Key Takeaways No statistically significant between-group difference appeared in IKDC-SKF at any measured time point, and scores improved over time in both groups. Seventy-five percent of the cohort returned to sport within 24 months, with similar 24-mo
- Meta-Analysis Links Heart Failure Therapies to Better Cardiac Function During Cancer Treatmenthttps://reachmd.com/news/heart-failure-cardiac-cancer-treatment/2487586/Key Takeaways RAAS inhibition plus beta blockers was associated with the largest reported LVEF gain among the more commonly studied therapies. RAAS inhibitors, beta blockers, and their combination were also associated with improved global longitudinal strain
- Robotic Versus Laparoscopic Radical Nephroureterectomy in UTUChttps://reachmd.com/news/robotic-laparoscopic-radical-nephroureterectomy-utuc-t3-ivr-signal/2487585/Key Takeaways Perioperative outcomes were comparable, and no remarkable differences were reported in disease-free or overall survival. Surgical platform was not significantly associated with cancer-specific mortality or intravesical recurrence in the o
- Skin Cancer Champions Earns Two Digital Health Awards for Patient Education and Community Engagementhttps://reachmd.com/news/skin-cancer-champions-earns-two-digital-health-awards-for-patient-education-and-community-engagement/2487580/Skin Cancer Champions, an online community dedicated to supporting patients and caregivers affected by non-melanoma skin cancers, has received two Bronze Awards in the Spring 2026 Digital Health Awards, presented by the Health Information Resource Center (HIRC). The awards recognize the or
- BOTOX Cosmetic Names 2026 Confidence Collective Entrepreneur Cohorthttps://reachmd.com/news/botox-cosmetic-names-2026-confidence-collective-entrepreneur-cohort/2487577/Allergan Aesthetics, an AbbVie company, has announced the 2026 cohort for The Confidence Collective: Empowering Women Entrepreneurs, a BOTOX® Cosmetic initiative designed to support women business owners through mentorship, education, and funding opportunities. According to the company, th